Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 13 - Jul 18
For Your Every Summer RSVP, with Code: SUMMER15
Description
Noom Med GLP 1 Medications for Weight Loss Menopause Weight Gain: Can GLP 1 Medications Help? The role of GLP1 receptor agonists in adult onset type 1 diabetes mellitus Nature Reviews Endocrinology Menopause Hormone Therapy May Boost GLP 1 Drug Benefits MedPage Today GLP 1 for Menopause Weight Gain: Complete Guide
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.9 ★★★★★
Based on 69 reviews
Sort
Product Reviews
★★★★★ 5
Good quality
Color: Off-white
Looks beautiful, very comfortable, good quality.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 13, 2025
★★★★★ 4
Cartera cómoda y práctica
Cartera cómoda, práctica, de piel genuina. No es muy grande pero tiene el espacio justo. Posee un bolsillo interior y el cierre es con imanes
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 30, 2025
★★★★★ 3
Pi o
The item wasĺwas too large for my body frame.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 8, 2026
★★★★★ 2
Too small
Color: Off-white
So much smaller than appears.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 1, 2026
★★★★★ 3
Is it really leather?
Doesn’t seem to be genuine leather but rather PVC
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 7, 2026
recommand products
New strategies for the treatment of obesity and metabolic dysfunctions
29.66
Strategic Design of Triple GLP-1R/GCGR/GIPR Agonists with Varied Receptor Potency: Achieving Comparable Glycemic and Weight Reduction Effects
25.76
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism
26.82
Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports
26.53
GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response
20.23